| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12K | — | +0.0% |
| R&D Expense | $2.3M | +103.6% | +61.2% |
| SG&A Expense | $4.7M | -16.9% | +30.9% |
| Operating Income | -$7.0M | -3.0% | -39.8% |
| Pre-tax Income | -$6.5M | -1.8% | -10.6% |
| Net Income | -$6.5M | -1.8% | -10.6% |
| EPS (Basic) | -$0.02 | +0.0% | +93.9% |
| EPS (Diluted) | -$0.02 | +0.0% | +93.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $68.9M | -6.0% | +3184.1% |
| Current Assets | $74.7M | -4.6% | +610.9% |
| Total Assets | $75.0M | -4.7% | +575.4% |
| Current Liabilities | $1.5M | -6.1% | -73.5% |
| Total Liabilities | $1.6M | -6.5% | -84.2% |
| Stockholders' Equity | $73.4M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.8M | -50.4% | — |
| Capital Expenditures | $6K | +200.0% | — |
| Investing Cash Flow | -$46K | -9.5% | — |
| Financing Cash Flow | $68.1M | +1.4% | — |
| Free Cash Flow | -$13.8M | -50.5% | — |
| +7506.8% |